February 12, 2024
Caramel Kettle Popcorn
May 31, 2022
Provo – UTAH – May 31, 2022 David Pratt, MD recently joined Provo Radiation Oncology as its newest provider. He will begin seeing patients in late June.
Dr. Pratt obtained a Bachelor of Arts at the University of Utah and a Doctor of Medicine at the Saint Louis University School of Medicine in St. Louis, Missouri. He also completed an internship at the Saint Louis University Hospital and a residency at the Barnes Jewish Hospital. Dr. Pratt is board certified by the American Board of Radiology and specializes in radiation oncology with a sub-specialty in stereotactic radiosurgery.
I am excited to be joining the team at Revere Health and relocating to the Utah Valley,” said Dr. Pratt. “My goal is to provide compassionate care to each patient and their family. I feel that by spending time with mypatients and educating them about their situation and what treatments are available to them, we can work together to achieve the best possible outcomes.
Revere Health Radiation Oncology offers a wide range of radiation therapy services including palliative care, electron beam radiation, CT simulations, and more. The team believes that high-quality, effective care is dependent on doctor-patient communication.
Revere Health is the largest independent multispecialty physician group in Utah and employs more than 200 physicians and 190 advanced practitioners. Founded in 1969, Revere Health has grown to include more than 100 clinics in both urban and rural areas throughout Utah and Nevada. Revere Health providers offer complete healthcare at every stage of life with multiple family practice locations and 30 medical specialties. As the first Accountable Care Organization accredited by Medicare in Utah, Revere Health is a leader in value-based care, which focuses on improving scientific measurements of health outcomes and lowering overall costs care. Revere Health takes a unique, patient-oriented approach to healthcare.
February 12, 2024
February 6, 2024
February 5, 2024
February 2, 2024